EP3522872
AMLODIPINE FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.10.2017EP published:
11.8.2021EP application number:
17859269.7
EPO information:
European Patent Register
Max expiry date:
5.10.2037
Title:
AMLODIPINE FORMULATIONS
Timeline
Today
6.10.2017EP application
11.8.2021EP Publication
Owner
Name:
Silvergate Pharmaceuticals, Inc.Address:
6251 Greenwood Plaza Blvd. Suite 101, Greenwood Village, CO 80111, US
Inventor
Name:
BRAUER, ScottAddress:
Harrisonville, Missouri 64701, US
Name:
MOSHER, Gerold L.Address:
Kansas City, Missouri 64145, US
Priority
Number:
201662405455 PDate:
7.10.2016Country:
US
Classification
Categories:
A61K 9/10, A61K 47/02, A61K 47/12, A61K 47/26, A61K 47/34, A61K 47/38, A61P 9/12, A61K 31/4422